Overview
A standardized clinical framework for reconstituting peptides intended for intranasal delivery. This protocol defines dilution ratios, spray-volume calculations, sterility handling, and stability parameters to ensure dosing precision and reproducibility across treatment cycles. All calculations are based on a calibrated nasal spray pump delivering approximately 0.1 mL per actuation.
Intranasal delivery may facilitate rapid systemic absorption and potential central distribution through olfactory and trigeminal pathways, making dosing accuracy critically important.
Standard Spray Volume
Each spray delivers approximately 0.1 mL.
All microgram calculations below are derived from this fixed spray volume.
If using a different spray device, calibration testing should be performed prior to clinical use.
Reconstitution Calculations by Peptide Strength
2mg Peptides
(Example: Oxytocin)
| 2 mL solution + 2 mg peptide Provides approximately 100 mcg per spray, yielding approximately 20 sprays |
| 1 mL solution + 2 mg peptide Provides approximately 200 mcg per spray, yielding approximately 10 sprays |
5mg Peptides
(Includes 5mg peptides or 5mg/5mg blends such as Semax/Selank)
| 5 mL solution + 5 mg peptide Provides approximately 100 mcg per spray |
10mg Peptides
(Includes 10mg peptides, 10mg/10mg blends, or dual 10mg combinations such as BPC-157 and KPV)
| 10 mL solution + 10 mg peptide Provides approximately 100 mcg per spray, yielding approximately 100 sprays |
| 5 mL solution + 10 mg peptide Provides approximately 200 mcg per spray, yielding approximately 50 sprays |
50mg Peptides
| 10 mL solution + 50 mg peptide Provides approximately 500 mcg per spray |
100mg Peptides
(Example: GHK-Cu)
| 10 mL solution + 100 mg peptide Provides approximately 1 mg per spray |
Preparation Procedure
| Use sterile bacteriostatic water or physician-approved diluent |
| Inject diluent slowly along the vial wall to avoid peptide foaming |
| Gently swirl — do not shake |
| Withdraw reconstituted solution using sterile technique |
| Transfer to sterile nasal spray bottle |
| Prime spray pump prior to first administration |
Sterility & Handling
Use sterile syringes and needles for every withdrawal.
Avoid repeated vial puncture beyond safe handling limits.
Do not use if solution appears cloudy, discolored, or particulate.
Storage
Store filled nasal spray bottles under refrigeration (2–8°C).
Avoid light exposure and repeated temperature fluctuations.
Expiration
Discard any reconstituted intranasal peptide solution after 30 days, regardless of remaining volume.
Clinical Considerations
| Dose titration should be individualized |
| Monitor for nasal mucosal irritation |
| Consider rotating nostrils with repeated dosing |
| Intranasal absorption may vary depending on mucosal condition |
| Avoid use during active sinus infection or significant nasal inflammation |
Rationale
Intranasal administration bypasses first-pass hepatic metabolism and may allow rapid systemic distribution. Because absorption occurs across a highly vascular mucosal surface, small variations in dilution can significantly impact delivered dose. Standardized reconstitution protocols ensure predictable microgram delivery per actuation and improve consistency across clinical applications.
Mathematical Calculation Tool
The calculator below allows mathematical concentration and volume calculations using variable vial strengths and reconstitution volumes. This tool is provided strictly for arithmetic reference.
Peptide Reconstitution Calculator
For Educational & Professional Reference Only
Clinical Disclaimer
This protocol is provided for informational and educational purposes for licensed healthcare professionals. These compounds and preparation strategies are not intended to diagnose, treat, cure, or prevent any disease. Patient-specific evaluation, sterile technique, and clinical judgment are required prior to implementation.